Status:
COMPLETED
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Lymphoma, Non-Hodgkin
Eligibility:
All Genders
4-75 years
Phase:
NA
Brief Summary
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
Detailed Description
To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tum...
Eligibility Criteria
Inclusion
- relapsed NHL
Exclusion
- liver dysfunction
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00186355
Start Date
October 1 2003
End Date
February 1 2010
Last Update
May 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305